NCT01397357

Brief Summary

The purpose of this study is to evaluate CARDIAC MAGNETIC RESONANCE UTILITIES IN THE ISCHEMIC HEART DISEASE as topographical correlation between ischemic territory injury and coronary angiography.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2011

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

July 18, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 19, 2011

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2015

Completed
Last Updated

October 3, 2016

Status Verified

May 1, 2015

Enrollment Period

3.4 years

First QC Date

July 18, 2011

Last Update Submit

September 30, 2016

Conditions

Keywords

Cardiac magnetic resonanceMyocardial IschemiaCoronary Artery Diseasesuspected Myocardial Ischemia

Outcome Measures

Primary Outcomes (1)

  • Accuracy of Cardio-RM identifying ischemic territories

    Assessing the accuracy of Cardio-RM identifying ischemic territories and their correspondence to the presence of critical coronary lesions, comparing the presence, extent and regional inducible ischaemia in the Cardiac-MRI with the presence and characteristics of vascular lesions in coronary angiography.

    1 month

Secondary Outcomes (2)

  • correlation between resonance and coronary artery disease documented coronary angiography.

    1 month

  • topographic correlation between ischemic territory and coronary lesions

    1 month

Study Arms (1)

suspected Myocardial Ischemia

Patient with diagnosis of suspected coronary artery disease (CAD) or recurrent ischemic symptoms assessed by under-effort angina symptoms and/or cardiac conventional stress test, and the presence of at least two risk factors.

Other: Cardiac magnetic resonance - CINE MRI stress test.

Interventions

Cardiac magnetic resonance - dipyridamole or dobutamine MRI stress test.

suspected Myocardial Ischemia

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who refer to the clinic within 12 months, with diagnosis of suspected coronary artery disease (CAD) or recurrent ischemic symptoms assessed by under-effort angina symptoms and/or cardiac conventional stress test, and the presence of at least two risk factors.

You may qualify if:

  • patients with suspected ischemic heart disease or recurrent Myocardial ischemic symptoms defined as:
  • presence of:
  • chest pain related to the effort lasting 5-20 minutes, and / or
  • positive stress test for inducible Myocardial ischemia
  • presence of at least one of the following risk factors: smoke family history of cardiovascular disease hypertension dyslipidemia diabetes mellitus NID / ID
  • no contraindications to perform coronary angiography
  • informed written consent to the processing of personal and sensible data, signed and dated by the patient.

You may not qualify if:

  • Unstable angina;
  • Severe aortic stenosis
  • Hypertrophic cardiomyopathy
  • Pacemaker and \\ or defibrillator
  • Coronary stent implantation in 90 days before Cardiac MRI
  • Intracranial metal clips
  • Severe hypertension (systolic blood pressure\> 240 mmHg, and diastolic blood pressure above 120 mmHg)
  • Ventricular thrombosis and \\ or atrial
  • Aortic aneurysm and \\ or aortic dissection
  • Myocarditis, endocarditis, pericarditis
  • Critical stenosis of the left notes
  • State of severe anxiety or claustrophobia
  • Contraindications to the use of atropine (BAV advanced glaucoma, pyloric stenosis, prostatic hypertrophy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maria Cecilia Hospital

Cotignola, RA, 48010, Italy

Location

MeSH Terms

Conditions

Myocardial IschemiaCoronary Artery Disease

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular DiseasesCoronary DiseaseArteriosclerosisArterial Occlusive Diseases

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2011

First Posted

July 19, 2011

Study Start

July 1, 2011

Primary Completion

December 1, 2014

Study Completion

March 1, 2015

Last Updated

October 3, 2016

Record last verified: 2015-05

Data Sharing

IPD Sharing
Will not share

Locations